Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Lymphocytic Leukemia, Chronic: early-phase trial registry
1 of 4 indexed Lymphocytic Leukemia, Chronic trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Lymphocytic Leukemia, Chronic: 4 US clinical trials tracked, 1 recruiting.
Lymphocytic Leukemia, Chronic is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Catapult Therapeutics, running 1 of these trials.
Enrollment posture brief
Registry condition lymphocytic-leukemia-chronic
OPEN 1 | RECR 25% | LATE 1 | EARLY 3 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Lymphocytic Leukemia, Chronic lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Lymphocytic Leukemia, Chronic on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Lymphocytic Leukemia, Chronic is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
Catapult Therapeutics
NCT04704323
Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia
Hoffmann-La Roche
NCT02242942
Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies
Washington University School of Medicine
NCT00241358
Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant
University of Michigan Rogel Cancer Center
NCT00143845
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Lymphocytic Leukemia, Chronic records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Lymphocytic Leukemia, Chronic trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Lymphocytic Leukemia, Chronic page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Lymphocytic Leukemia, Chronic trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Catapult Therapeutics sponsors the most Lymphocytic Leukemia, Chronic trials on record, review their full trial history before evaluating a specific study. See Catapult Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Lymphocytic Leukemia, Chronic condition card totals 4 registered trials; most-linked intervention Prophylactic donor leukocyte infusions; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.